Arginine binding motifs: Design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors

Journal of Medicinal Chemistry

Volumn 51, Issue 7, 2008, Pages 2297-2301

  Öberg, Christopher T ^a   Leffler, Hakon ^a   Nilsson, Ulf J ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BENZAMIDE; GALACTOSE; GALECTIN 3; GUANIDINE DERIVATIVE; METHYL 3 DEOXY 3 (4 METHYLBENZAMIDO) 1 THIO BETA DEXTRO GALACTOPYRANOSIDE; PHOSPHATE; PYRANOSIDE; SULFATE; UNCLASSIFIED DRUG;

ARTICLE; MODEL; SYNTHESIS;

ARGININE; BENZAMIDES; BINDING SITES; BINDING, COMPETITIVE; DRUG DESIGN; GALACTOSE; GALACTOSIDES; GALECTIN 3; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OXYGEN; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 41849118385     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701266y     Document Type: Article

References (49)

1. Zick, Y.; Eisenstein, M.; Goren, R. A.; Hadari, Y. R.; Levy, Y.; Ronen, D. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconjugate J. 2004, 19, 517-526.
2. Ochieng, J.; Furtak, V.; Lukyanov, P. Extracellular functions of galectin-3. Glycoconjugate J. 2004, 19, 527-535.
3. Rabinovich, G. A.; Toscano, M. A.; Ilarregui, J. M.; Rubinstein, N. Shedding light on the immunomodulator y proper ties of galectins: Novel regulators of innate and adaptive immune responses. Glycoconjugate J. 2004, 19, 565-573.
4. Huflejt, M.; Leffler, H. Galectin-4 in normal tissues and cancer. Glycoconjugate J. 2004, 20, 247-255.
5. Takenaka, Y.; Fukumori, T.; Raz, A. Galectin-3 and metastasis. Glycoconjugate J. 2004, 19, 543-549.
6. Patterson, R. J.; Wang, W.; Wang, J. L. Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconjugate J. 2004, 19, 499-506.
7. Hsu, D. K.; Liu, F. T. Regulation of cellular homeostasis by galectins. Glycoconjugate J. 2004, 19, 507-515.
8. Lahm, H.; Andre, S.; Hoeflich, A.; Kaltner, H.; Siebert, H. C.; Sordat, B.; von der Lieth, C.-W.; Wolf, E.; Gabius, H.-J. Tumor galectinology: Insights into the complex network of a family of endogenous lectins. Glycoconjugate J. 2004, 20, 227-238.
9. Leffler, H.; Carlsson, S.; Hedlund, M.; Qian, Y. Introduction to galectins. Glycoconjugate J. 2004, 19, 433-440.
10. Dumic, J.; Dabelic, S.; Flögel, M. Galectin-3: An open-ended story. Biochim. Biophys. Acta 2006, 1760, 616-635.
11. Camby, I.; Le Mercier, M.; Lefranc, F.; Kiss, R. Galectin-1: A small protein with major functions. Glycobiology 2006, 16, 137R-157R.
12. Perillo, N. L.; Pace, K. E.; Seilhamer, J. J.; Baum, L. G. Apoptosis of T cells mediated by galectin-1. Nature 1995, 378, 736-739.
13. Nakahara, S.; Oka, N.; Raz, A. On the role of galectin-3 in cancer apoptosis. Apoptosis 2005, 10, 267-275.
14. Delacour, D.; Greb, C.; Koch, A.; Salomonsson, E.; Leffler, H.; Le Bivic, A.; Jacob, R. Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic 2007, 8, 379-388.
15. Rabinovich, G. A.; Liu, F.-T.; Anderson, A. An emerging role for galectins in tuning the immune response: Lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand. J. Immunol. 2007, 66, 143-158.
16. Toscano, M. A.; Bianco, G. A.; Ilarregui, J. M.; Croci, D. O.; Correale, J.; Hernandez, J. D.; Zwirner, N. W.; Poirer, F.; Riley, E. M.; Baum, L.; Rabinovich, G. A. Differential glycosylation of TH1, TH2, and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immun. 2007, 825, 834.
17. Demetriou, M.; Granovsky, M.; Quaggin, S.; Dennis, J. W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001, 409, 733-739.
18. Partridge, E. A.; Le Roy, C.; Di Guglielmo, G. M.; Pawling, J.; Cheung, P.; Granovsky, M.; Nabi, I. R.; Wrana, J. L.; Dennis, J. W. Regulation of cytokine receptors by golgi N-glycan processing and endocytosis. Science 2004, 306, 120-124.
19. Lau, K. S.; Partridge, E. A.; Grigorian, A.; Silvescu, C. I.; Reinhold, V. N.; Demetriou, M.; Dennis, J. W. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007, 129, 123-134.
20. Elola, M. T.; Wolfenstein-Todel, C.; Troncoso, M. F.; Vasta, G. R.; Rabinovich, G. A. Galectins: Matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell. Mol. Life Sci. 2007, 64, 1679-1700.
21. Almkvist, J.; Karlsson, A. Galectins as inflammatory mediators. Glycoconjugate J. 2004, 19, 575-581.
22. Hirashima, M.; Kashio, Y.; Nishi, N.; Yamauchi, A.; Imaizumi, T. A.; Kageshita, T.; Saita, N.; Nakamura, T. Galectin-9 in physiological and pathological conditions. Glycoconjugate J. 2004, 19, 593-600.
23. Sato, S.; Nieminen, J. Seeing strangers or announcing "danger": Galectin-3 in two models of innate immunity. Glycoconjugate J. 2004, 19, 583-591.
24. Rubinstein, N.; Toscano, M. A.; Ilarrgui, J. M.; Bianco, G. A.; Rabinovich, G. A. The sweet kiss of death: A link between galectin-1, glycosylation and the generation of immune privilege. Trends Glycosci. Glycotechnol. 2005, 17, 133-143.
25. Ilarregui, J. M.; Bianco, G. A.; Toscano, M. A.; Rabinovich, G. A. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorder. Ann. Rheum. Dis. 2005, 64, iv96-iv103.
26. Liu, F.-T. Regulatory roles of galectins in the immune response. Int. Arch. Allergy Immunol. 2005, 136, 385-400.
27. Rabinovich, G. A. Galectin-1 as a potential cancer target. Br. J. Cancer 2005, 92, 1188-1192.
28. Liu, F.-T.; Rabinovich, G. A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5, 29-41.
29. Saussez, S.; Kiss, R. Galectin-7. Cell. Mol. Life Sci. 2006, 63, 686-697.
30. Carlsson, S.; Öberg, C. T.; Carlsson, M. C.; Sundin, A.; Nilsson, U. J.; Smith, D.; Cummings, R. D.; Almkvist, J.; Karlsson, A.; Leffler, H. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 2007, 17, 663-676.
31. Carlsson, S.; Carlsson, M. C.; Leffler, H. Intracellular sorting of galectin-8 based on carbohydrate fine specificity. Glycobiology 2007, 17, 906-912.
32. Pieters, R. J. Inhibition and detection of galectins. ChemBioChem 2006, 7, 721-728.
33. Sörme, P.; Qian, Y.; Nyholm, P.-G.; Leffler, H.; Nilsson, U. J. Low micromolar inhibitors of galectin-3 based on 3′-derivatization of N-acetyllactosamine. ChemBioChem 2002, 3, 183-189.
34. Sörme, P.; Arnoux, P.; Kahl-Knutsson, B.; Leffler, H.; Rini, J. M.; Nilsson, U. J. Structural and thermodynamic studies on cation-Π interactions in lectin-ligand complexes: High-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction. J. Am. Chem. Soc. 2005, 127, 1737-1743.
35. Cumpstey, I.; Sundin, A.; Leffler, H.; Nilsson, U. J. C2-Symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: Efficient lectin inhibition through double arginine-arene interactions. Angew. Chem., Int. Ed. 2005, 44, 5110-5112.
36. 2+-mobilizing activity of purine-modified mimics of Adenophostin A: A model for the Adenophostin-Ins(1,4,5)P3 receptor interaction. J. Med. Chem. 2003, 46, 4860-4871.
37. Borissow, C. N.; Black, S. J.; Paul, M.; Tovey, S. C.; Dedos, S. G.; Taylor, C. W.; Potter, B. V. L. Adenophostin A and analogues modified at the adenine moiety: Synthesis, conformational analysis and biological activity. Org. Biomol. Chem. 2005, 3, 245-252.
38. Rensing, S.; Arendt, M.; Springer, A.; Grawe, T.; Schrader, T. Optimization of a synthetic arginine receptor. Systematic tuning of noncovalent interactions. J. Org. Chem. 2001, 66, 5814-5821.
39. Renner, C.; Piehler, J.; Schrader, T. Arginine- and lysine-specific polymers for protein recognition and immobilization. J. Am. Chem. Soc. 2006, 128, 620-628.
40. Schmuck, C.; Rupprecht, D.; Junkers, M.; Schrader, T. Artificial ditopic Arg-Gly-Asp (RGD) receptors. Chem. - Eur. J. 2007, 13, 6864-6873.
41. Lindh, I.; Stawinski, J. A general method for the synthesis of glycerophospholipids and their analogs via H-phosphonate intermediates. J. Org. Chem. 1989, 54, 1338-1342.
42. Garegg, P. J.; Regberg, T.; Stawinski, J.; Strömberg, R. Nucleoside phosphonates: Part 7. Studies on the oxidation of nucleoside phosphonate esters. J. Chem. Soc., Perkin Trans. 1 1987, 1269, 1273.
43. Barili, P. L.; Berti, G.; Catelani, G.; Colonna, F.; Marra, A. New results in the isopropylidenation of galactopyranosides. Useful intermediates for the synthesis of galactose derivatives. Tetrahedron Lett. 1986, 27, 2307-2310.
44. Sonne, P.; Kahl-Knutsson, B.; Huflejt, M.; Nilsson, U. J.; Leffler, H. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Anal. Biochem. 2004, 334, 36-47.
45. Kumar, S.; Nussinov, R. Salt bridge stability in monomeric proteins. J. Mol. Biol. 1999, 293, 1241-1255.
46. Sörme, P.; Kahl-Knutsson, B.; Wellmar, U.; Nilsson, U. J.; Leffler, H. Fluorescence polarization to study galectin-ligand interactions. Methods Enzymol. 2003, 362, 504-512.
47. Sörme, P.; Kahl-Knutsson, B.; Wellmar, U.; Magnusson, B.-G.; Leffler, H.; Nilsson, U. J. Design and synthesis of galectin inhibitors. Methods Enzymol. 2003, 363, 157-169.
48. PDB id code 1 kjl.
49. PDB id code 1 kjr.